J&J Faces New Challenge To Schizophrenia Drug

Law360 (November 16, 2005, 12:00 AM EST) -- India-based generic drug maker Dr. Reddy’s Laboratories Ltd. has been sued by Johnson & Johnson for attempting to manufacture and sell a generic version of its popular drug for schizophrenia and bipolar I disorder.

J&J filed the suit through its Belgium-based subsidiary Janssen Pharmaceutica NV and its New Jersey-based partners Janssen Pharmaceutical Products LP. The suit was filed in the U.S. District Court for the District of New Jersey.

The suit was triggered by Dr. Reddy’s January filing with the U.S. Food and Drug Administration of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.